financetom
Business
financetom
/
Business
/
Lilly partners with Amazon to deliver Zepbound and other drugs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lilly partners with Amazon to deliver Zepbound and other drugs
Mar 13, 2024 3:44 AM

March 13 (Reuters) - Eli Lilly ( LLY ) said on Wednesday

it has brought on Amazon.com's ( AMZN ) pharmacy unit to deliver

drug prescriptions sent to its direct-to-consumer service,

LillyDirect.

Lilly launched the platform in January to enable patients to

obtain their migraine, diabetes and obesity drugs, including the

popular weight-loss medicine Zepbound, directly from the company

via delivery from online pharmacy Truepill.

The drugmaker said prescriptions sent to LillyDirect

Pharmacy Solutions would now be delivered by either Amazon

Pharmacy or Truepill, depending on the patient's insurance

coverage and other factors.

Lilly's vice president of managed healthcare services, Frank

Cunningham, said they planned to split the orders between the

two companies. He said Lilly was "very pleased" with the number

of prescriptions it had filled through LillyDirect but declined

to share the number.

A Lilly spokesperson said in an emailed statement that the

website has generated significant interest since the launch and

that the drugmaker "looked forward to continuing to enhance

LillyDirect with additional medicines, partners and service

providers in the near future."

Cunningham said the Indianapolis-based drugmaker was

considering partnering with a retail pharmacy to offer a pick-up

option for LillyDirect customers.

Walgreens CEO Tim Wentworth told Reuters shortly

after LillyDirect was launched that the pharmacy chain could be

"a very natural potential partner for someone like Lilly."

LillyDirect was launched on the back of surging demand last

year for powerful weight-loss drugs including Zepbound and Novo

Nordisk's Wegovy.

The market for obesity drugs is estimated to reach at least

$100 billion by the end of the decade, as consumers flock to the

new treatments that have been shown to reduce weight by as much

as 20%.

Lilly CEO David Ricks told Reuters in January that the

website would ensure that coupons that bring the cost of

Zepbound down to $550 a month were applied, and would also

encourage users to avoid compounded or fake versions of the

medicine.

The website also connects patients to independent telehealth

providers who can complement their current team of doctors or be

an alternative to in-person care for certain conditions, the

company has previously said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia-Backed Serve Robotics Pops On Q2 Earnings: Everything You Need To Know
Nvidia-Backed Serve Robotics Pops On Q2 Earnings: Everything You Need To Know
Aug 13, 2024
Serve Robotics Inc ( SERV ) shares are moving higher in Tuesday’s after-hours session on the heels of the company’s second-quarter financial results. Q2 Revenue: $468,375, versus estimates of $400,000 Q2 EPS: Loss of 27 cents, versus estimates for a loss of 25 cents Serve averaged 385 daily supply hours during the second quarter, representing a 106% increase year-over-year. The company noted that...
Grail Q2 Net Loss Widens, Revenue Rises; Cost Cuts Planned; Shares Jump After Hours
Grail Q2 Net Loss Widens, Revenue Rises; Cost Cuts Planned; Shares Jump After Hours
Aug 13, 2024
05:16 PM EDT, 08/13/2024 (MT Newswires) -- Grail (GRAL) reported a Q2 net loss late Tuesday of $51.06 per diluted share, widening from $6.22 a year earlier. Revenue in the quarter ended June 30 rose to $32 million from $22.4 million a year earlier. The Q2 net loss of $1.59 billion included goodwill and intangible impairment of $1.42 billion. Grail...
Box Insider Sold Shares Worth $351,676, According to a Recent SEC Filing
Box Insider Sold Shares Worth $351,676, According to a Recent SEC Filing
Aug 13, 2024
05:23 PM EDT, 08/13/2024 (MT Newswires) -- Dylan C Smith, Chief Financial Officer, on August 09, 2024, sold 13,000 shares in Box (BOX) for $351,676. Following the Form 4 filing with the SEC, Smith has control over a total of 1,513,661 shares of the company, with 1,513,661 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1372612/000095017024096438/xslF345X03/ownership.xml Price: 27.61, Change: -0.19, Percent Change: -0.68...
Cargojet Swings to an Unexpected Second-Quarter Loss Despite Higher Revenue
Cargojet Swings to an Unexpected Second-Quarter Loss Despite Higher Revenue
Aug 13, 2024
05:23 PM EDT, 08/13/2024 (MT Newswires) -- Cargojet ( CGJTF ) on Tuesday said it swung to an unexpected second-quarter adjusted loss on higher costs. The airfreight carrier said its loss excluding items was $0.8 million, or $0.05 per share, in the period, compared with an adjusted profit of $15.8 million, or $0.91, in the year-prior quarter. The result lagged...
Copyright 2023-2026 - www.financetom.com All Rights Reserved